Quality systems that surpass GMP obligations
Our Canadian site aligns with Health Canada, FDA, EMA, and ISO frameworksâdelivering trusted biologics with zero critical findings.
Global certification wall
Inspection milestones and certificates are curated in our digital trust centre, accessible to partners in English and French.
Licence No. 10245 renewed 2024 with commendation on digital deviation tracking.
Biologics licence operations inspected 2023âno Form 483 observations issued.
EU GMP certificate (FR/EMA/PI/145) sustained with yearly remote review.
Integrated management system audited by CSA Group with zero major non-conformities.
Computerised systems verified for data integrity, audit trails, and bilingual access.
CSA Z1000 and WHMIS compliance covering biosafety level 2 laboratories.
Quality document centre
Authorised partners can download bilingual SOPs, batch records, and certificates through secure identity management.
| Document | Language | Access |
|---|---|---|
| Plasma fractionation master batch record | EN / FR | Request via portal |
| Deviation & CAPA procedure | EN / FR | Request via portal |
| Supplier qualification checklist | EN / FR | Request via portal |
| Annual product review summary | EN / FR | Request via portal |
Supplier integrity and scorecards
Continuous monitoring safeguards plasma inputs, reagents, and logistics partners.
Qualification & onboarding
Risk-based audits evaluate GMP alignment, sustainability, and bilingual documentation.
Scorecard rating ⢠92/100
Environmental, social & governance (ESG)
We embed sustainability and community commitments within our GMP framework.
âOur ESG commitments mirror the trust our patients and partners place in Canadian-made plasma therapeutics.â â Marie-Ăve Gagnon, VP Quality & Compliance